Circulating Matrix Metalloproteinase-7: An Early or Metastatic Marker for Renal Cell Carcinoma?

Jung, Klaus; Ramankulov, Azizbek; Schrader, Mark; Miller, Kurt; Lein, Michael

doi:10.1373/clinchem.2008.109249

Cited by 2 publications

(1 citation statement)

References 5 publications

(4 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In colorimetry, Peng Chen et al demonstrated its use for MMP-7 detection with a detection limit of 0.1µg/mL [28]. However, as MMP physiological concentrations in respective carcinomas are between a few ng/ml to µg/ml [8,9,29,30], this method is not sensitive enough, especially for early stage cancer diagnosis. Furthermore, as there are several types of carcinomas that correlate with multiple MMPs, achieving accurate analysis and diagnosis require monitoring of the concentrations of multiple MMPs level simultaneously.…”

Section: Introductionmentioning

confidence: 99%

Sensitive surface enhanced Raman scattering multiplexed detection of matrix metalloproteinase 2 and 7 cancer markers

Gong¹,

Kong²,

Goh³

et al. 2015

Biomed. Opt. Express

View full text Add to dashboard Cite

A surface enhanced Raman spectroscopy (SERS) based platform was developed for sensitive multiplexed detection of matrix metalloproteinases (MMP) (MMP-2 and MMP-7) with low limit of detection and high specificity. Detection is based on the virtue of enzymatic reaction where a peptide can be cleaved only by its corresponding enzyme. The platform comprises two components, a specialized SERS-based bimetallic-film-over-nanosphere (BMFON) substrate and gold nanoparticles (AuNPs). The two components were functionalized such that binding between the two would occur through biotin-avidin-biotin complexation. Binding is hindered by MMP peptide chains conjugated onto the surfaces of the substrate and AuNPs, and can be removed only by cleaving the peptide chains with corresponding enzymes. Since AuNP binding sites become free after the peptides are cleaved, the number of binding sites for AuNPs onto the substrate would increase. By tagging the AuNPs, concentrations of MMP-specific enzymes can be quantified through examining intensities of signature SERS peaks of the tags. This cleave-and-bind mechanism was first validated by individual detection and quantification of MMP-2 and MMP-7. The platform was demonstrated to be able to sensitively detect concentrations of specific enzymes ranging from 1 ng/mL to 40 µg/mL, with close correlation between SERS intensity and concentrations. Finally, the multiplexed detection of MMP-2 and MMP-7 was demonstrated. The multiplexity of this platform provides a robust way to analyze diseases associated with MMP-2 and MMP-7 enzymes. Our work can be further developed as a clinical diagnostic tool to detect other MMP proteinase in bio-fluids samples, widening the number of biomarkers needed to characterize diseases better.

show abstract